Ny coronavaccine viser lovende resultater. I anden testfase for vaccinen fra franske Sanofi og britiske GlaxoSmithKline har det vist sig, at mellem 95 og 100 pct. af forsøgspersonerne udvikler antistoffer efter andet vaccinestik. Det oplyser Sanofi i en pressemeddelelse. Hvis alt går vel forventes coronavaccinen at blive godkendt i fjerde kvartal i år.
Silicon Valley00:00Mexico City00:00New York00:00Sao Paulo00:00Nuuk00:00Bangui00:00Linköping00:00Kyjiv00:00Kabul00:00Mumbai00:00Hong Kong00:00Shanghai00:00Sydney00:00Fransk Polynesien00:00Silicon Valley00:00Mexico City00:00New York00:00Sao Paulo00:00Nuuk00:00Bangui00:00Linköping00:00Kyjiv00:00Kabul00:00Mumbai00:00Hong Kong00:00Shanghai00:00Sydney00:00Fransk Polynesien00:00Silicon Valley00:00Mexico City00:00New York00:00Sao Paulo00:00Nuuk00:00Bangui00:00Linköping00:00Kyjiv00:00Kabul00:00Mumbai00:00Hong Kong00:00Shanghai00:00Sydney00:00Fransk Polynesien00:00Silicon Valley00:00Mexico City00:00New York00:00Sao Paulo00:00Nuuk00:00Bangui00:00Linköping00:00Kyjiv00:00Kabul00:00Mumbai00:00Hong Kong00:00Shanghai00:00Sydney00:00Fransk Polynesien00:00
1
2
3
4
5
6
7
8
9
10
11
12
